Abstract Details
|
Jorge G. Ortiz-Garcia, MD, FAAN
(The University of Oklahoma Health Sciences Center)
PRESENTER |
Dr. Ortiz-Garcia has nothing to disclose. |
| Michael W. Doerrler, DO (Gundersen Health System) | No disclosure on file |
| Preston Douglas, MD (Newport Neurology) | No disclosure on file |
| Michael J. Schneck, MD, FAAN (Loyola University Chicago, Stritch School of Medicine) | An immediate family member of Dr. Schneck has received personal compensation for serving as an employee of Cellcarta. Dr. Schneck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for HLT Medical. Dr. Schneck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miscellaneous legal firms. Dr. Schneck has stock in Baxter Labs. The institution of Dr. Schneck has received research support from NIH. |
| Matthew A. McCoyd, MD (Loyola University, Stritch School of Medicine) | Dr. McCoyd has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. McCoyd has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. |